340 Participants Needed

Hospital to Home Transition for Childhood Asthma

(H2H Trial)

Recruiting at 1 trial location
KP
JC
AM
Overseen ByAlicia Mathis
Age: < 18
Sex: Any
Trial Phase: Academic
Sponsor: Kavita Parikh
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores ways to better support children with asthma after hospital discharge. It examines whether an "asthma navigator" can help families manage asthma care more effectively than standard support. Participants will receive either standard care or additional guidance through the Hospital to Home Transition (H2H) program, addressing asthma challenges at home and school over a year. Families with children aged 4-12 who have been hospitalized for asthma, reside in the DC, Maryland, or Virginia area, and speak English or Spanish may be eligible to join. As an unphased trial, this study offers families the chance to contribute to innovative asthma care strategies that could enhance daily life for children with asthma.

Do I need to stop my child's current medications for this asthma trial?

The trial information does not specify whether participants need to stop taking their current medications. It is best to consult with the trial coordinators for specific guidance.

What prior data suggests that this Hospital to Home Transition is safe for children with asthma?

A previous study showed that the Hospital to Home Transition (H2H) program is both practical and well-received, meaning it was easy to implement and appreciated by patients and families. Importantly, no reports of serious side effects emerged from the program.

The main feature of the H2H program is the use of asthma navigators. These trained professionals help families manage asthma care after leaving the hospital. They work closely with doctors, schools, and families to ensure children follow their asthma action plans.

Since the study is labeled "Not Applicable" for a specific phase, it likely focuses on testing the program's approach rather than a new drug. This suggests the intervention centers on coordinating care, which tends to be safer as it involves guidance rather than new medications.

Overall, the H2H program appears well-tolerated, with no major safety concerns identified so far. This could reassure families considering participation in the trial.12345

Why are researchers excited about this trial?

Researchers are excited about the Hospital to Home Transition (H2H) program for childhood asthma because it offers a personalized, hands-on approach that goes beyond the typical standard of care. Most current treatments focus on medication and in-hospital care, but H2H provides a multi-component support system that includes an asthma navigator. This navigator helps families manage asthma care at home and maintains communication with primary care doctors and school nurses. By addressing challenges in the child's daily environment, this approach aims to reduce hospital readmissions and improve overall asthma management for children.

What evidence suggests that the Hospital to Home Transition (H2H) intervention is effective for childhood asthma?

Research has shown that the Hospital to Home Transition (H2H) program, which participants in this trial may receive, can assist children with asthma after hospital discharge. Early studies indicate that initiating detailed care planning while a child is still hospitalized is feasible and appreciated by families. This approach aims to enhance children's healthcare use and asthma management at home, potentially reducing emergency visits and hospital readmissions. Evidence also suggests that home monitoring of asthma, a component of the H2H program, can cut emergency visits and hospital stays by about half. This improvement means children could manage their asthma better and enjoy a higher quality of life.13678

Who Is on the Research Team?

KP

Kavita Parikh, MD MSHS

Principal Investigator

Children's National Research Institute

Are You a Good Fit for This Trial?

This trial is for English or Spanish-speaking caregivers living in DC, Maryland, or Virginia with a child aged 4-12 hospitalized due to asthma. Caregivers must be at least 18 years old.

Inclusion Criteria

My child, aged 4-12, is hospitalized for asthma.
Your residence is within the District of Columbia, Maryland, or Virginia area.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

During hospital admission
1 visit (in-person)

Baseline Data Collection

Baseline data will be collected from caregivers during the child's hospital admission for asthma exacerbation

During hospital admission
1 visit (in-person)

Intervention

Intervention arm receives standard of care plus asthma navigator support post-discharge

12 months
Up to 15 contacts (mixed in-person and virtual)

Control

Control arm receives standard of care post-discharge

12 months

Follow-up

Participants are monitored for safety and effectiveness after treatment

12 months
Data collection at 3, 6, 9, and 12 months (in-person or via telehealth)

What Are the Treatments Tested in This Trial?

Interventions

  • Hospital to Home Transition (H2H)
Trial Overview The study tests a 'Hospital to Home' (H2H) program where after hospital discharge, one group gets standard care while the other also receives support from an asthma navigator. Participants are randomly assigned to these groups.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Hospital to Home Transition (H2H)Experimental Treatment1 Intervention
Group II: Standard of CareActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Kavita Parikh

Lead Sponsor

Trials
1
Recruited
340+

Published Research Related to This Trial

From 2000 to 2016, the incidence of adverse drug events related to anti-asthmatic medications in hospitalized children increased significantly, from 5.3 to 21.6 per 1000 discharges, indicating a growing concern for safety in pediatric asthma treatment.
Children aged 0-4 years experienced the most dramatic rise in adverse events from bronchodilators, highlighting the need for careful monitoring and management of asthma medications in this vulnerable age group.
Adverse Drug Events Related to Common Asthma Medications in US Hospitalized Children, 2000-2016.Xie, L., Gelfand, A., Mathew, MS., et al.[2022]
Caregivers of children with asthma highlighted significant challenges in managing asthma care after hospital admissions, including unclear follow-up pathways and inconsistent advice, which can lead to readmissions.
They proposed effective solutions such as personalized Written Asthma Action Plans, early access to preventer medications, and improved community-based asthma support services to enhance care and potentially reduce future hospital visits.
Understanding caregiver perspectives on challenges and solutions to pediatric asthma care for children with a previous hospital admission: a multi-site qualitative study.Jones, R., Turner, B., Perera, P., et al.[2022]
A review of 71 studies found that pediatric discharge interventions, particularly those focusing on follow-up care, discharge planning, and parental education, can improve caregiver satisfaction and potentially reduce subsequent healthcare use.
Interventions that included bundled care coordination and family engagement were especially effective in lowering healthcare use for patients with chronic illnesses and neonates, suggesting targeted strategies can enhance hospital-to-home transitions.
Hospital-to-Home Interventions, Use, and Satisfaction: A Meta-analysis.Hamline, MY., Speier, RL., Vu, PD., et al.[2023]

Citations

1.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/32664809/
Outcomes from a pilot patient-centered hospital-to-home ...Conclusion: These pilot data suggest that comprehensive care coordination initiated during the inpatient stay is feasible and acceptable. A larger trial is ...
Outcomes from a Pilot Patient-Centered Hospital-to-Home ...Primary outcomes included feasibility and acceptability. Secondary outcomes included healthcare utilization, asthma morbidity, and caregiver quality of life.
Care transition interventions for children with asthma in the ...This review summarizes the evidence regarding care transition interventions originating in the ED for children with uncontrolled asthma.
Improving Pediatric Asthma Care and Outcomes Across ...Overall, improved asthma outcomes occurred without any increase in hospital resource use and no change in PICU transfer or death. At community ...
Children with asthma who use at-home monitoring are half ...Children with asthma who use at-home monitoring are around half as likely to visit the emergency department or be hospitalised, ...
Hospital to Home Transition for Childhood Asthma (H2H Trial)The H2H medical study, being run by Kavita Parikh, is evaluating whether Hospital to Home Transition (H2H) will have tolerable side effects & efficacy for ...
Managing the Health of Children with Asthma from ... - PolicyLabPrior research has shown that only 60% to 75% of children with persistent asthma fill a prescription for controller medications over an entire year and the ...
The Family Perspective on Hospital to Home TransitionsHospital-level compliance with asthma care quality measures at children's hospitals and subsequent asthma-related outcomes. JAMA . 2011.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security